The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Recent News

Esperion Therapeutics Partners with The Chase Group

February 18, 2015
Esperion Therapeutics has retained The Chase Group to secure a Chief Medical Officer responsible for the overall direction, planning, execution and interpretation of clinical research… Continue Reading →

Ipsen Neurology Franchise VP Secured

January 14, 2015 0 Comments
The Chase Group is proud to announce they recently completed a search for Vice President, Neurology Franchise for Ipsen US. Donald Pearl has been hired… Continue Reading →

The Chase Group Fills Key Leadership Role for Marinus Pharmaceuticals

January 12, 2015
The Chase Group is proud to announce the completion of a search for the Chief Medical Officer for Marinus Pharmaceuticals with the hiring of Albena… Continue Reading →

Acorda Therapeutics and The Chase Group Partner Once Again

January 12, 2015
Acorda Therapeutics has retained The Chase Group to secure a Medical Director of Clinical and Medical Affairs to join their rapidly expanding clinical development team…. Continue Reading →

RRD International Retains The Chase Group

January 12, 2015
RRD International has retained The Chase Group to secure a Chief Development Officer to direct and manage the day-to-day activities of all RRD International product… Continue Reading →

Ipsen VP Neurology Franchise Secured

January 12, 2015
The Chase Group is proud to announce they recently completed a search for Vice President, Neurology Franchise for Ipsen US. Donald Pearl has been hired… Continue Reading →

Ipsen Biosciences Retains The Chase Group for Neuroendocrine Position

October 23, 2014
Ipsen Biosciences has retained The Chase Group to secure a Director of Molecular and Cellular Endocrinology who will lead the company’s research programs to devise… Continue Reading →

Marinus Pharmaceuticals Retains The Chase Group

September 19, 2014
Marinus Pharmaceuticals has retained The Chase Group to secure a Chief Medical Officer to lead the overall direction, planning, execution and interpretation of medical affairs,… Continue Reading →

Durata Therapeutics and The Chase Group Partner Once Again

August 28, 2014
Durata Therapeutics has retained The Chase Group to secure two Executive Directors of Clinical and Medical Affairs to join their rapidly expanding clinical development team…. Continue Reading →

TCG Continues Successful Collaboration with Isis Pharmaceuticals

August 28, 2014
The Chase Group announces the recruitment of Dr. Fred Derosier as Executive Director, Clinical Development. Dr. Derosier is excited to join such a dynamic organization,… Continue Reading →
© Copyright 1993-2020 The Chase Group; All Rights Reserved.